{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:36:34Z","timestamp":1773419794488,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.lfs.2014.11.001","type":"journal-article","created":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T10:10:31Z","timestamp":1415787031000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A novel highly potent and selective 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499"],"prefix":"10.1016","volume":"120","author":[{"given":"Soo Young","family":"Byun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young June","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ky Youb","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Pyo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Kil","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2014.11.001_bb0005","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1210\/en.2003-0344","article-title":"Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains","volume":"144","author":"Alberts","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2014.11.001_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.metabol.2012.05.002","article-title":"11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?","volume":"62","author":"Anagnostis","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2014.11.001_bb0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1210\/jc.2002-021194","article-title":"Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes","volume":"88","author":"Andrews","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2014.11.001_bb0020","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/CS19980388","article-title":"Glucocorticoids and insulin resistance: old hormones, new targets","volume":"96","author":"Andrews","year":"1999","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.lfs.2014.11.001_bb0025","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1021\/jm025530f","article-title":"Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1","volume":"45","author":"Barf","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2014.11.001_bb0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1124\/jpet.107.128280","article-title":"Demonstration of proof of mechanism and pharmacokinetics and pharmacodynamic relationship with 4'-cyano-biphenyl-4-sulfonic acid (6-amino-pyridin-2-yl)-amide (PF-915275), an inhibitor of 11 -hydroxysteroid dehydrogenase type 1, in cynomolgus monkeys","volume":"324","author":"Bhat","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2014.11.001_bb0035","doi-asserted-by":"crossref","first-page":"E116","DOI":"10.1152\/ajpendo.00331.2003","article-title":"Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes","volume":"286","author":"Diani","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2014.11.001_bb0040","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbadis.2009.10.017","article-title":"The role of 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension","volume":"1802","author":"Ferrari","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2014.11.001_bb0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1507\/endocrj.43.645","article-title":"Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM","volume":"43","author":"Friedman","year":"1996","journal-title":"Endocr. J."},{"key":"10.1016\/j.lfs.2014.11.001_bb0050","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/diabetes.49.5.759","article-title":"A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice","volume":"49","author":"Fukui","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2014.11.001_bb0055","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/0091270010374470","article-title":"Population pharmacokinetic\/pharmacodynamic model of subcutaneous adipose 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) activity after oral administration of AMG 221, a selective 11beta-HSD1 inhibitor","volume":"51","author":"Gibbs","year":"2011","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2014.11.001_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1747-0285.2007.00603.x","article-title":"Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor","volume":"71","author":"Hale","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.lfs.2014.11.001_bb0065","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.20050119","article-title":"11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice","volume":"202","author":"Hermanowski-Vosatka","year":"2005","journal-title":"J Exp. Med."},{"key":"10.1016\/j.lfs.2014.11.001_bb0070","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1734-1140(12)70903-9","article-title":"11beta-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome","volume":"64","author":"Joharapurkar","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2014.11.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1039\/9781849735322","article-title":"New therapeutic strategies for type 2 diabetes: small molecule approaches","volume":"27","author":"Jones","year":"2012","journal-title":"RSC Drug Discov."},{"key":"10.1016\/j.lfs.2014.11.001_bb0080","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1172\/JCI119175","article-title":"Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets","volume":"99","author":"Lambillotte","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2014.11.001_bb0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/endo.141.2.7297","article-title":"Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats","volume":"141","author":"Livingstone","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2014.11.001_bb0090","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","article-title":"A transgenic model of visceral obesity and the metabolic syndrome","volume":"294","author":"Masuzaki","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.lfs.2014.11.001_bb0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1248\/cpb.50.100","article-title":"Novel 5-substituted-1H-tetrazole derivatives as potent glucose and lipid lowering agents","volume":"50","author":"Momose","year":"2002","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.lfs.2014.11.001_bb0100","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1517\/13543784.2010.504713","article-title":"11beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes","volume":"19","author":"Morgan","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.lfs.2014.11.001_bb0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mce.2009.09.024","article-title":"Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease","volume":"316","author":"Morton","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2014.11.001_bb0110","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diabetes.53.4.931","article-title":"Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice","volume":"53","author":"Morton","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2014.11.001_bb0115","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.metabol.2011.06.012","article-title":"The effects of glucocorticoids on adipose tissue lipid metabolism","volume":"60","author":"Peckett","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2014.11.001_bb0120","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1463-1326.2012.01582.x","article-title":"11beta-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus","volume":"14","author":"Pereira","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.lfs.2014.11.001_bb0125","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1210\/jcem.86.3.7453","article-title":"Tissue-specific dysregulation of cortisol metabolism in human obesity","volume":"86","author":"Rask","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2014.11.001_bb0130","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/dc09-2315","article-title":"The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2014.11.001_bb0135","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2337\/diabetes.54.3.872","article-title":"Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone","volume":"54","author":"Sandeep","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2014.11.001_bb0140","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1021\/jm300592r","article-title":"Discovery of a potent, selective, and orally bioavailable acidic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitor: discovery of 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acet ic acid (AZD4017)","volume":"55","author":"Scott","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2014.11.001_bb0145","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/endo.142.4.8114","article-title":"Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action","volume":"142","author":"Seckl","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2014.11.001_bb0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bmcl.2006.10.008","article-title":"Adamantane sulfone and sulfonamide 11-beta-HSD1 Inhibitors","volume":"17","author":"Sorensen","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2014.11.001_bb0155","first-page":"451","article-title":"Animal models in type 2 diabetes research: an overview","volume":"125","author":"Srinivasan","year":"2007","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.lfs.2014.11.001_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2210-8-3","article-title":"Inhibition of 11betaHSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy mice","volume":"8","author":"Sundbom","year":"2008","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.lfs.2014.11.001_bb0165","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/diabetes.48.9.1830","article-title":"Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice","volume":"48","author":"Tang","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2014.11.001_bb0170","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1016\/j.bmcl.2010.08.142","article-title":"Discovery and optimization of adamantyl carbamate inhibitors of 11beta-HSD1","volume":"20","author":"Tice","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2014.11.001_bb0175","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/01.HYP.27.6.1346","article-title":"Carbenoxolone damages endothelium and enhances vasoconstrictor action in aortic rings","volume":"27","author":"Ullian","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2014.11.001_bb0180","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/14728222.7.6.771","article-title":"11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease","volume":"7","author":"Walker","year":"2003","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2014.11.001_bb0185","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1021\/jm900639u","article-title":"Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model","volume":"52","author":"Wan","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2014.11.001_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-7075-2-3","article-title":"The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome","volume":"2","author":"Wang","year":"2005","journal-title":"Nutr. Metab. (Lond.)"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051400900X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432051400900X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T08:14:45Z","timestamp":1566029685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432051400900X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":38,"alternative-id":["S002432051400900X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2014.11.001","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel highly potent and selective 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2014.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}